US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist
  • 61.455
  • +0.105+0.17%
Trading Mar 11 11:09 ET
5.22BMarket Cap-28.45P/E (TTM)

About Verona Pharma Company

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.

Company Profile

SymbolVRNA
Company NameVerona Pharma
Listing DateApr 27, 2017
Issue Price13.50
Founded2005
CEODr. David Zaccardelli, Pharm.D.
MarketNASDAQ
Employees209
Securities TypeDR
ADS Ratio1.0 : 8.0
Fiscal Year Ends12-31
Address3 More London Riverside
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeSE1 2RE
Phone44-203-283-4200
Websitehttp://www.veronapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David Zaccardelli, Pharm.D.
  • Executive Director,Chief Executive Officer and President
  • --
  • Piers John Morgan
  • Executive Director,Chief Financial Officer
  • --
  • Professor Dr. David Raymond Ebsworth, PhD
  • Non-Executive Director,Chairman
  • --
  • Lisa Deschamps
  • Non-Executive Director
  • --
  • Vikas Sinha
  • Non-Executive Director
  • --
  • Dr. Mahendra Gopaldas Shah, PhD
  • Non-Executive Director
  • --
  • Sven Anders Ernst Uddo Ullman
  • Non-Executive Director
  • --
  • Michael Austwick
  • Non-Executive Director
  • --
  • Christina M. Ackermann
  • Non-Executive Director
  • --
  • Dr. Martin William Edwards, M.D.
  • Non-Executive Director
  • --
  • Dr. Kenneth Thomas Cunningham
  • Non-Executive Director
  • --
  • James Brady
  • Non-Executive Director
  • --
  • Ben Harber
  • Company Secretary
  • --

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Coinbase
COIN
192.820
Tesla
TSLA
229.945
Strategy
MSTR
247.376
4
Salesforce
CRM
278.175
5
Amazon
AMZN
197.560
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!